Background Idiopathic pulmonary fibrosis (IPF) is a progressive debilitating lung disease
with considerable morbidity. Heterogeneity in epidemiologic studies means the full impact of …

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease characterized by
progressive lung scarring and the histological picture of usual interstitial pneumonia (UIP). It …

Background Since 2009, IPF patients across Europe are recruited into the eurIPFreg,
providing epidemiological data and biomaterials for translational research. Methods The …

Objective. To describe pulmonary involvement at time of diagnosis in antineutrophil
cytoplasmic antibodies (ANCA)-associated vasculitis (AAV), as defined by computed …

Interstitial lung disease (ILD) is a collective term representing a diverse group of pulmonary
fibrotic and inflammatory conditions. Due to the diversity of ILD conditions, paucity of …

Background Patients with idiopathic pulmonary fibrosis (IPF) frequently have multiple
comorbidities, which may influence survival but go under-recognised in clinical practice. We …

Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease with increasing
occurrence, high death rates, and unfavorable treatment regimens. The pathogenesis …

Pulmonary fibrosis is a chronic progressive interstitial lung disease caused by a variety of
etiologies. The disease can eventually lead to irreversible damage to the lung tissue …

Pulmonary fibrosis is the end-stage change of a large class of lung diseases characterized
by the proliferation of fibroblasts and the accumulation of a large amount of extracellular …

Background The association between long-term air pollution exposure and the development
of idiopathic pulmonary fibrosis (IPF) has been established, but the evidence regarding the …